Morbidity and Mortality Weekly Report, June 18, 1999 / 48(23);496-497
Centers for Disease Control and Prevention
Effective June 7, 1999, the National Nonoccupational HIV Postexposure Prophylaxis (PEP) Registry opened for enrollment. The registry was established as a prospective surveillance project to monitor isolated episodes of potential HIV exposures through sexual activity, injecting-drug use, and other nonoccupational events. Receipt of antiretroviral PEP is not an eligibility requirement for enrollment in the registry. Registration and data collection are available through telephone, fax, postal mail, and a World-Wide Web site.
Information is being confidentially collected about the type of exposure, the decision to use or not use PEP, drugs taken, risk-reduction referrals made, and results of HIV-antibody tests. No names or other identifying information about patients will be collected. Information will be reported nationally and used in collaboration with data in the registries of other nations to monitor the use of PEP for nonoccupational HIV exposures and its clinical outcomes. Providers will receive a small reimbursement for the time spent reporting.
Additional information about the registry is available from the Nonoccupational HIV PEP Registry, telephone (toll-free 24 hours) (877) 448-1737 or the World-Wide Web, http://www.HIVpepregistry.org.*
* References to sites of nonfederal organizations on the World-Wide Web are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites.
Disclaimer: All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.
NOTE: MMWR's are in Portable Document Format (PDF) to retain the original format. To view or print these documents, you must use the Adobe Acrobat viewer. Acrobat is free and available directly from Adobe's website with full installation instructions. 
Download MM4823
980618
MM4823
Copyright © 1999 - All material in the MMWR Series is in the public domain and may be used and reprinted without special permission; citation as to source, however, is appreciated.
AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1990, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.